The abnormal loss of nuclear Pax-2 expression is observed in approximately 70–80% of cases of EC and atypical hyperplasia/endometrial intraepithelial neoplasia (AH/EIN) (24). Here, PAX2 is linked to Endometrial Intraepithelial Neoplasia.